China Universal Asset Management Co., Ltd. Fate Therapeutics Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 20,216 shares of FATE stock, worth $19,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,216
Previous 23,024
12.2%
Holding current value
$19,407
Previous $25,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FATE
# of Institutions
155Shares Held
81.5MCall Options Held
46.4KPut Options Held
17.5K-
Redmile Group, LLC San Francisco, CA12.9MShares$12.4 Million1.79% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$9.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.8MShares$8.45 Million0.0% of portfolio
-
Wilshire Advisors LLC Santa Monica, CA8.49MShares$8.15 Million27.71% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.38MShares$3.24 Million1.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $93.1M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...